Skip to Content

FDA wants to simplify the use and updating of COVID-19 vaccines

<i>Sarah Silbiger/Getty Images</i><br/>The Food and Drug Administration (FDA) wants to simplify the Covid-19 vaccine process. Pictured is the FDA headquarters on July 20
Getty Images
Sarah Silbiger/Getty Images
The Food and Drug Administration (FDA) wants to simplify the Covid-19 vaccine process. Pictured is the FDA headquarters on July 20

By Jamie Gumbrecht, CNN

The US Food and Drug Administration wants to simplify the COVID-19 vaccine process to look more like what happens with the flu vaccine, according to documents posted online on Monday. That could include streamlining the vaccine composition, immunization schedules and periodic updates of COVID-19 vaccines.

The FDA said it expects to assess circulating strains of the virus that causes COVID-19 at least annually and decide in June which strains to select for the fall season, much like the process to update annual flu vaccines.

Moving forward, the agency said, most people may need only one dose of the latest COVID-19 shot to restore protection, regardless of how many shots they have already received. Two doses may be needed for people who are very young and haven’t been exposed, or for the elderly or immune-compromised, according to the FDA’s briefing document for its vaccine advisers.

The agency is urging a shift toward only one vaccine composition, rather than a combination of monovalent vaccines, which are currently used for primary shots and target only one strain, and bivalent vaccines, which are currently used for booster doses and target more than one strain.

“This simplification of vaccine composition should reduce complexity, decrease vaccine administration errors due to the complexity of the number of different vial presentations, and potentially increase vaccine compliance by allowing clearer communication,” the FDA said.

The FDA’s plan was first reported by National Public Radio.

The agency’s independent vaccine advisers, the Vaccines and Related Biological Products Advisory Committee, are scheduled to meet on Thursday to discuss the future of COVID-19 vaccine regimens, and will be asked to vote on whether they recommend parts of FDA’s plan.

™ & © 2023 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.

Article Topic Follows: Coronavirus Coverage

Jump to comments ↓

CNN Newsource


KIFI Local News 8 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content